UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): February 1320, 2009

Aperture Health, Inc.

(Exact name of registrant as specified in charter)

Nevada	000-09283	20-8085447
(State or Other Jurisdiction	(Commission File	(IRS Employer
of Incorporation)	Number)	Identification No.)

27201 Puerta Real, Suite 350

Mission Viejo, CA 92691

(Address of Principal Executive Offices) (Zip Code)

949-609-1966

(Registrant’s telephone number, including area code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 5.02 – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 1320, 2009, the Company received a letter of resignation from ~~Steven~~Heidi ~~Geringer~~Patterson, Director, with due effect from February 1320, 2009. MrMs. ~~Geringer~~Patterson informed the Company that ~~his~~her decision to resign was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. ~~The Company announced the appointment of Mr. Jerome D. Nourse, by the Board of Directors, to fill the vacancy created by the resignation of Mr. Geringer.~~

Item 9.01. Financial Statements and Exhibits.

None.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

APERTURE HEALTH, INC. By: /s/ Thomas Banks Name: Thomas Banks Title: Chairman and Chief Executive Officer Dated: February 1820, 2009

Filing Compare · Aperture Health, Inc.